[HTML][HTML] Atrial fibrillation in the elderly

P Diez-Villanueva, F Alfonso - Journal of geriatric cardiology: JGC, 2019 - ncbi.nlm.nih.gov
Atrial fibrillation (AF) is the most common arrhythmia in elderly population, with age being
one of the most important factors involved in its pathogenesis. Conduction disturbances may …

Utilización de los anticoagulantes orales de acción directa en Atención Primaria de España. Posicionamiento de SEMERGEN ante la situación actual

JLL Caro, S Cinza-Sanjurjo, JP Garcia… - Medicina de Familia …, 2019 - Elsevier
Los anticoagulantes orales de acción directa (ACOD) son fármacos que han demostrado
tener un perfil de seguridad superior a los antivitamina K (AVK). En España la prescripción …

[HTML][HTML] Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2018

CB Cuixart, JJA Sánchez, JRB Banegas… - Atención …, 2018 - ncbi.nlm.nih.gov
Las enfermedades del sistema circulatorio son la primera causa de muerte para el conjunto
de la población española. En el año 2016 causaron en España 119.778 muertes (55.307 en …

Evaluation of SAMe-TT2R2 score and other clinical factors influencing the quality of anticoagulation therapy in non-valvular atrial fibrillation: a nationwide study in …

JM Lobos-Bejarano, V Barrios… - … medical research and …, 2016 - Taylor & Francis
Objective: To assess the major clinical factors affecting the quality of anticoagulation and
evaluate the predictive value of the SAMe-TT2R2 score to identify patients who will achieve …

Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

JM Mostaza, C Suarez, JM Cepeda, L Manzano… - BMC Cardiovascular …, 2021 - Springer
Background This study assessed the sociodemographic, functional, and clinical
determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation (NVAF) …

Profiling of patients with non-valvular atrial fibrillation and moderate-to-high risk of stroke not receiving oral anticoagulation in Spain

JP García, DV Ortega, F Formiga, I Unzueta… - Medicina de Familia …, 2019 - Elsevier
Objective In non-valvular atrial fibrillation (NVAF) with embolic risk, the guidelines
recommend oral anticoagulation (OAC), although not all patients receive it. In this study, an …

[PDF][PDF] Recomendaciones preventivas cardiovasculares. PAPPS 2016

AM Galán, CB Cuixart, JRB Banegas, EM Rioboó… - Atención …, 2016 - sahta.com
Las enfermedades del sistema circulatorio son la primera causa de muerte para el conjunto
de la población española. En el año 2013 causaron en España 117.484 muertes (53.487 en …

Impact of type 2 diabetes mellitus in hospitalizations for atrial fibrillation in Spain (2004–2013)

M Méndez-Bailón, N Muñoz-Rivas… - International Journal of …, 2016 - Elsevier
Background To describe trends in the incidence and outcomes for atrial fibrillation (AF) in
patients with and without type 2 diabetes (T2DM) in Spain between 2004 and 2013 …

A new risk score to assess atrial fibrillation risk in hypertensive patients (ESCARVAL-RISK Project

D Orozco-Beltran, JA Quesada… - Scientific Reports, 2020 - nature.com
This study aimed to assess atrial fibrillation (AF) incidence and predictive factors in
hypertensive patients and to formulate an AF risk assessment score that can be used to …

Risk factors and therapeutic coverage at 6 years in patients with previous myocardial infarction: the CASTUO study

FJ Félix-Redondo, LL Mera, L Consuegra-Sánchez… - Open …, 2016 - openheart.bmj.com
Objectives To determine the degree of risk factor control, the clinical symptoms and the
therapeutic management of patients with a history of previous myocardial infarction …